Marcondes J A, Santomauro A T, Minanni S L, Wajchenberg B L
Endocrine Division, Hospital das Clinicas, Sao Paulo, Brazil.
Horm Metab Res. 1991 Dec;23(12):605-8. doi: 10.1055/s-2007-1003765.
To investigate the hypothesis of an altered hypothalamic dopaminergic activity in primary hypothyroidism, eight patients with hypothyroidism and seven normal subjects, all female, were studied. All of them were submitted to two tests: TRH stimulation and after the administration of dopamine receptor-blocking drug, Domperidone. The hypothyroid patients with basal TSH values less than or equal to 60 mU/L (4 cases--group 1) had lower PRL levels than the remaining 4 subjects with TSH greater than 60 mU/L (group 2) (p less than 0.001), despite all patients presenting the PRL levels within the normal range. A significant increase occurred for both TSH and PRL after the administration of TRH and Domperidone in normal as well as in the hypothyroid subjects, except for TSH in group 1 after the administration of Domperidone. The area under the curve for PRL response to THR was not different between the normal subjects and both hypothyroid groups, while that under the curve for TSH was greater in the hypothyroidism as a whole than in the normal subjects (p = 0.006) and between the hypothyroid groups, being greater in group 2 than in 1 (p less than 0.009). In relation to Domperidone, the area under the curve for TSH was significantly higher in group 2 when compared to the normal controls (p less than 0.001), while for PRL it was not different between hypothyroid groups in relation to normal controls and when groups I and II were compared. These results suggest that the hypothalamic dopamine activity is not altered in primary hypothyroidism and favor the small relevance of dopamine on the control of TSH secretion.
为了研究原发性甲状腺功能减退症时下丘脑多巴胺能活性改变的假说,对8例甲状腺功能减退症患者和7名正常受试者(均为女性)进行了研究。所有受试者均接受了两项测试:促甲状腺激素释放激素(TRH)刺激试验以及在服用多巴胺受体阻断药物多潘立酮后进行的测试。基础促甲状腺激素(TSH)值小于或等于60 mU/L的甲状腺功能减退症患者(4例,第1组)的催乳素(PRL)水平低于其余4名TSH大于60 mU/L的受试者(第2组)(p<0.001),尽管所有患者的PRL水平均在正常范围内。正常受试者和甲状腺功能减退症患者在服用TRH和多潘立酮后,TSH和PRL均显著升高,但第1组患者在服用多潘立酮后TSH除外。正常受试者与两个甲状腺功能减退症组之间,PRL对TRH反应的曲线下面积无差异,而整个甲状腺功能减退症组TSH的曲线下面积大于正常受试者(p = 0.006),且在两个甲状腺功能减退症组之间,第2组大于第1组(p<0.009)。关于多潘立酮,与正常对照组相比,第2组TSH的曲线下面积显著更高(p<0.001),而对于PRL,甲状腺功能减退症组与正常对照组相比以及第I组和第II组比较时均无差异。这些结果表明,原发性甲状腺功能减退症时下丘脑多巴胺活性未改变,且支持多巴胺在促甲状腺激素分泌控制中相关性较小的观点。